These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3558203)

  • 1. Artificial pulmonary surfactant inhibited by proteins.
    Fuchimukai T; Fujiwara T; Takahashi A; Enhorning G
    J Appl Physiol (1985); 1987 Feb; 62(2):429-37. PubMed ID: 3558203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro.
    Cockshutt AM; Weitz J; Possmayer F
    Biochemistry; 1990 Sep; 29(36):8424-9. PubMed ID: 2252903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of some serum components and proteolytic products of fibrinogen on surface tension-lowering abilities of beractant and a synthetic peptide containing surfactant KL4.
    Manalo E; Merritt TA; Kheiter A; Amirkhanian J; Cochrane C
    Pediatr Res; 1996 Jun; 39(6):947-52. PubMed ID: 8725253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of palmitic acid in pulmonary surfactant: enhancement of surface activity and prevention of inhibition by blood proteins.
    Cockshutt AM; Absolom DR; Possmayer F
    Biochim Biophys Acta; 1991 Sep; 1085(2):248-56. PubMed ID: 1892895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro inhibition of biophysical surface properties and change in ultrastructures of exogenous pulmonary surfactant by albumin or fibrinogen.
    Park J; Bae CW; Choi YM
    J Korean Med Sci; 1998 Apr; 13(2):123-30. PubMed ID: 9610611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A coagulative type of pulmonary surfactant depletion--a mechanism of damage to the pulmonary surfactant system].
    Koga Y
    Hokkaido Igaku Zasshi; 1994 May; 69(3):434-44. PubMed ID: 7927172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.
    Seeger W; Grube C; Günther A; Schmidt R
    Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between plasma proteins and pulmonary surfactant: pulsating bubble studies.
    Keough KM; Parsons CS; Tweeddale MG
    Can J Physiol Pharmacol; 1989 Jun; 67(6):663-8. PubMed ID: 2476209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of surfactant function by copper-zinc superoxide dismutase (CuZn-SOD).
    Haddad IY; Nieves-Cruz B; Matalon S
    J Appl Physiol (1985); 1997 Nov; 83(5):1545-50. PubMed ID: 9375318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidylcholine sensitizes lipid extracts of pulmonary surfactant to inhibition by serum proteins.
    Cockshutt AM; Possmayer F
    Biochim Biophys Acta; 1991 Oct; 1086(1):63-71. PubMed ID: 1954245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of simultaneous exposure of surfactant to serum proteins and free radicals.
    Marzan Y; Mora R; Butler A; Butler M; Ingenito EP
    Exp Lung Res; 2002 Mar; 28(2):99-121. PubMed ID: 11868826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles.
    Beck-Broichsitter M; Ruppert C; Schmehl T; Günther A; Seeger W
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):474-81. PubMed ID: 24184425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer.
    Seeger W; Stöhr G; Wolf HR; Neuhof H
    J Appl Physiol (1985); 1985 Feb; 58(2):326-38. PubMed ID: 3838543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant protein SP-B counteracts inhibition of pulmonary surfactant by serum proteins.
    Friedrich W; Schmalisch G; Stevens PA; Wauer RR
    Eur J Med Res; 2000 Jul; 5(7):277-82. PubMed ID: 10903187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextran restores albumin-inhibited surface activity of pulmonary surfactant extract.
    Kobayashi T; Ohta K; Tashiro K; Nishizuka K; Chen WM; Ohmura S; Yamamoto K
    J Appl Physiol (1985); 1999 Jun; 86(6):1778-84. PubMed ID: 10368337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of captive and pulsating bubble surfactometers with use of lung surfactants.
    Putz G; Goerke J; Taeusch HW; Clements JA
    J Appl Physiol (1985); 1994 Apr; 76(4):1425-31. PubMed ID: 8045815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo.
    Strayer DS; Herting E; Sun B; Robertson B
    Am J Respir Crit Care Med; 1996 Mar; 153(3):1116-22. PubMed ID: 8630554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of surfactant subtypes of beractant and a synthetic peptide containing surfactant KL4 following surface area cycling and addition of fibrinogen.
    Manalo E; Merritt TA; Amirkhanian JD; Kheiter A
    Lung; 1997; 175(4):225-33. PubMed ID: 9195550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method for the isolation and preparation of surfactant from tracheobronchial aspirates in infants and children for quantitative and pulsating bubble analysis.
    Raymondos K; Martin-Carrera I; Bernhard W; Poets C; von der Hardt H
    Eur J Clin Invest; 1996 Nov; 26(11):983-8. PubMed ID: 8957204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs.
    Wang Z; Chang Y; Schwan AL; Notter RH
    Am J Respir Cell Mol Biol; 2007 Oct; 37(4):387-94. PubMed ID: 17556674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.